Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Silo Pharma(SILO) the EBIT is -928.95 K (+25.6%);the EPS is -0.758 (+73.64%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B25.60%
----
----
EPS
-0.758173.64%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf